Digital Education for Hypertension Management: Effects on Self-Care and Health Literacy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorBartın Unıversity
About this trial
The goal of this clinical trial is to learn whether a digital education program can help people with high blood pressure (hypertension) manage their condition better. The program aims to improve self-care behaviors and health literacy by teaching participants how to use digital tools, follow healthy lifestyle habits, and take their medicines regularly.
Researchers will compare two groups. One group will receive digital education that includes short videos, brochures, and podcasts about blood pressure control and how to use online health platforms such as e-Nabız (Turkey's national e-health system). The other group will not receive this education. Participants will attend two sessions during two weeks.
The main questions are:
Does digital education improve self-care and e-health literacy in people with hypertension? Does it help participants take their medicine as prescribed and maintain healthy habits such as diet and exercise?
Eligibility criteria
Qualifiers
Adults aged 50 years or older
Individuals with a clinical diagnosis of hypertension or those regularly using antihypertensive medication
Individuals actively registered at the Life Center and receiving regular services
Participants who provide written and verbal informed consent to voluntarily join the study
Disqualifiers
Individuals without a diagnosis of hypertension
Individuals unable to complete questionnaires or education sessions due to communication barriers or cognitive limitations
Illiterate individuals, as data collection requires reading and completing written questionnaires
Individuals unable to maintain participation or adhere to the follow up schedule during the study period
Trial design
Treatments tested in this trial
- Hypertension Self-Management and E-Health Education
Treatment groups
166 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov